DÄ internationalArchive5/2007Innate Immunity – the Clinical Significance of Endogenous Antimicrobial Peptides in Internal Medicine and Dermatology

Review article

Innate Immunity – the Clinical Significance of Endogenous Antimicrobial Peptides in Internal Medicine and Dermatology

Dtsch Arztebl 2007; 104(5): A-257

Wehkamp, J; Bals, R; Kreft, B; Schröder, J; Stange, E F

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Hornef MW, Wick MJ, Rhen M et al.: Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 2002; 3: 1033–40. MEDLINE
2. Schroder JM, Harder J: Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006; 63: 469–86. MEDLINE
3. Bals R: Antimikrobielle Peptide und Peptidantibiotika. Medizinische Klinik. München: Urban und Vogel 2000; 95: 496–502.
4. Wehkamp J, Fellermann K, Herrlinger K et al.: Mechanisms of disease: defensins in gastrointestinal diseases. Nature Clin Pract 2005; 2: 406–15. MEDLINE
5. Harder J, Bartels J, Christophers E et al.: A peptide antibiotic from human skin. Nature 1997; 387: 861. MEDLINE
6. Harder J, Bartels J, Christophers E et al.: Isolation and characterization of human ??-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707–13. MEDLINE
7. Harder J, Schroder JM: RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. Journal of Biological Chemistry 2002; 277: 46779–84. MEDLINE
8. Gläser R, Harder J, Lange H et al.: Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol; 2005; 6: 57–64. MEDLINE
9. Ong PY, Ohtake T, Brandt C et al.: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151–60. MEDLINE
10. Salzman NH, Ghosh D, Huttner KM et al.: Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422: 522–6. MEDLINE
11. Islam DF, Bandholtz LF, Nilsson JF et al.: Downregulation of bactericidal peptides in enteric infections: an immune escape mechanism with bacterial DNA as a potential regulato. Nat Med 2001; 7: 180–5. MEDLINE
12. Wehkamp J, Schmidt K, Herrlinger KR et al.: Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol 2003; 56: 352–7. MEDLINE
13. Wehkamp J, Harder J, Weichenthal M et al.: NOD2 (CARD15) mutations in Crohn´s disease are associated with diminished mucosal a-defensin expression. Gut 2004; 53: 1658–64. MEDLINE
14. Wehkamp J, Salzman NH, Porter E et al.: Reduced Paneth cell {alpha}-defensins in ileal Crohn's disease. PNAS 2005; 102: 18129–34. MEDLINE
15. Kobayashi KS, Chamaillard M, Ogura Y et al.: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731–4. MEDLINE
16. Wehkamp J, Harder J, Weichenthal M et al.: Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2003; 9: 215–23. MEDLINE
17. Schauber J, Rieger D, Weiler F et al.: Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2006; 18: 615–21. MEDLINE
18. Fellermann K, Stange DE, Schaeffeler E et al.: A chromosome 8 gene cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn´s disease of the colon. Am J Hum Genet. 2006; 79: 439–48. MEDLINE
19. Wehkamp J, Harder J, Wehkamp K et al.: NF-kB and AP-1 mediated induction of human beta defensin-2 in intestinal epithelial cells by MEDLINE
E. coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004; 72: 5750–8.
20. Bals R, Wang X, Wu Z et al.: Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998; 102: 874–80. MEDLINE
21. Bals R, Wang X, Zasloff M et al.: The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998; 95: 9541–6. MEDLINE
22. Bals R: Roles of antimicrobial peptides in pulmonary disease. In: Devine DA, Hancock RE, eds.: Mammalian host defense peptides. Cambridge: Cambridge University Press 2004; 349–74.
23. Nitschke M, Wiehl S, Baer PC et al.: Bactericidal activity of renal tubular cells: the putative role of human beta-defensins. Exp Nephrol 2002; 10: 332–7. MEDLINE
24. Ganz T: Defensins in the urinary tract and other tissues. J Infect Dis 2001; 183 (Suppl. 1): S41–2. MEDLINE
25. Kruis W, Fric P, Pokrotnieks J et al.: Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617–23. MEDLINE
e1. Fleming A: On a remarkable bacteriolytic element found in tissues and excretions 1922; 93, 306–310.
e2. Chronnell CM, Ghali LR, Ali RS, et al.: Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol 2001; 117: 1120–5. MEDLINE
e3. Ayabe T, Satchell DP, Wilson CL et al.: Secretion of microbicidal alpha-defensins by intestinal Paneth cel response to bacteria. Nat Immunol 2000; 1: 113–8. MEDLINE
e4. Wilson CL, Ouellette AJ, Satchell DP et al.: Regulation of intestinal -defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999; 286: 113–7. MEDLINE
e5. Kiehne K, Brunke G, Meyer D et al.: Oesophageal defensin expression during Candida infection and reflux disease. Scand J Gastroenterol 2005; 40: 501–7. MEDLINE
e6. Wehkamp J, Fellermann K, Herrlinger KR et al.: Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14: 745–52. MEDLINE
e7. Fahlgren A, Hammarstrom S, Danielsson A et al.: beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol 2004; 137: 379–85. MEDLINE
e8. Wehkamp J, Schmid M, Fellermann K et al.: Defensin deficiency, intestinal microbes and clinical phenotypes of Crohn's disease. J Leukoc Biol 2005 Apr; 77: 460–5. MEDLINE
e9. Whitsett JA: Intrinsic and innate defenses in the lung: intersection of pathways regulating lung morphogenesis, host defense, and repair. J Clin Invest 2002; 109(5): 565–9. MEDLINE
e10. Moser C, Weiner DJ, Lysenko E et al.: beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 2002; 70: 3068–72. MEDLINE
e11. Nizet V, Ohtake T, Lauth X et al.: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414: 454–7. MEDLINE
e12. Yang D, Biragyn A, Hoover DM et al.: Multiple Roles of Antimicrobial Defensins, Cathelicidins, and Eosinophil-Derived Neurotoxin in Host Defense. Annu Rev Immunol 2004; 22: 181–215. MEDLINE
e13. Tjabringa GS, Aarbiou J, Ninaber DK et al.: The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003; 171: 6690–6. MEDLINE
e14. Yang D, Chertov O, Bykovskaia S et al.: beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286: 525–8. MEDLINE
e15. Koczulla R, von Degenfeld G, Kupatt C et al.: An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111(11): 1665–72. MEDLINE
e16. Heilborn JD, Nilsson MF, Jimenez CI et al.: Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 2005; 114: 713–9. MEDLINE
e17. Matsushita I, Hasegawa K, Nakata K et al.: Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2002; 291: 17–22. MEDLINE
e18. Hu RC, Xu YJ, Zhang ZX et al.: Correlation of HDEFB1 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population. Chin Med J (Engl ) 2004; 117: 1637–41. MEDLINE
e19. Saemann MD, Weichhart T, Horl WH et al.: Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection. Eur J Clin Invest 2005; 35: 227–35. MEDLINE

Info

Specialities